May 2006
Volume 47, Issue 13
ARVO Annual Meeting Abstract  |   May 2006
Surgical Outcomes of Vitreomacular Traction Syndrome With and Without Indocyanine Green Assisted Internal Limiting Membrane Peeling
Author Affiliations & Notes
  • S. Bazzaz
    Ophthalmology, Baylor, Houston, TX
  • R.R. Lakhanpal
    Ophthalmology, Baylor, Houston, TX
  • T.A. Albini
    Ophthalmology, Baylor, Houston, TX
  • W.F. Mieler
    Ophthalmology, Baylor, Houston, TX
  • M.S. Benz
    Ophthalmology, Baylor, Houston, TX
  • E.R. Holz
    Ophthalmology, Baylor, Houston, TX
  • Footnotes
    Commercial Relationships  S. Bazzaz, None; R.R. Lakhanpal, None; T.A. Albini, None; W.F. Mieler, None; M.S. Benz, None; E.R. Holz, None.
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 3243. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S. Bazzaz, R.R. Lakhanpal, T.A. Albini, W.F. Mieler, M.S. Benz, E.R. Holz; Surgical Outcomes of Vitreomacular Traction Syndrome With and Without Indocyanine Green Assisted Internal Limiting Membrane Peeling . Invest. Ophthalmol. Vis. Sci. 2006;47(13):3243.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : To compare surgical outcomes of eyes with vitreomacular traction syndrome (VMTS) treated with and without Indocyanine Green (ICG)–assisted Internal Limiting Membrane (ILM) peeling.

Methods: : A retrospective review of patient charts, operative reports, photographs, and optical coherence tomography images was performed for all patients diagnosed with VMTS and treated surgically by three surgeons at the Baylor College of Medicine from July 1996 to July 2005. Ninety–two eyes of 80 patients were in the study group. Forty–eight eyes were treated with vitrectomy and posterior hyaloid separation alone (Group 1); forty–four eyes were treated with vitrectomy, posterior hyaloid separation and ICG–assisted ILM peeling (Group 2). Mean follow–up time was 36 months (range, 12–62 months) overall. Group 1 follow–up was 33 months (range, 16–62 months) and Group 2 follow–up was 28 months (range, 12–52 months).

Results: : Complete posterior vitreous separation and macular reattachment was achieved in all VMTS eyes. Seventy–nine eyes (86%) achieved two or more lines of visual improvement: Thirty–seven eyes in Group 1 (77.1%) and 42 eyes in Group 2 (95.5%). Mean macular thickness at one year as measured by OCT was 222.5 µm in Group 1 eyes and 134.5 µm in Group 2 eyes. Twenty–six eyes (28.3%) developed symptomatic epiretinal membranes with thickening on OCT by one year: Twenty eyes in Group 1 (77.0%) had a mean macular thickness of 255.4 µm and 6 eyes in Group 2 (23.1%) had a mean macular thickness of 173.5 µm.

Conclusions: : Treatment of VMTS with ICG–assisted ILM peeling may improve visual outcomes and reduce the incidence of re–proliferation of glial tissue resulting in postoperative epiretinal membranes.

Keywords: vitreoretinal surgery • retinal adhesion • macula/fovea 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.